BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38059827)

  • 1. Metabolic Enzyme SLC27A5 Regulates PIP4K2A pre-mRNA Splicing as a Noncanonical Mechanism to Suppress Hepatocellular Carcinoma Metastasis.
    Nie D; Tang X; Deng H; Yang X; Tao J; Xu F; Liu Y; Wu K; Wang K; Mei Z; Huang A; Tang N
    Adv Sci (Weinh); 2024 Feb; 11(5):e2305374. PubMed ID: 38059827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLC27A5 deficiency activates NRF2/TXNRD1 pathway by increased lipid peroxidation in HCC.
    Gao Q; Zhang G; Zheng Y; Yang Y; Chen C; Xia J; Liang L; Lei C; Hu Y; Cai X; Zhang W; Tang H; Chen Y; Huang A; Wang K; Tang N
    Cell Death Differ; 2020 Mar; 27(3):1086-1104. PubMed ID: 31367013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutathione reductase.
    Xu FL; Wu XH; Chen C; Wang K; Huang LY; Xia J; Liu Y; Shan XF; Tang N
    Cell Death Dis; 2023 Jan; 14(1):22. PubMed ID: 36635256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skipping of exon 10 in
    Shen L; Lei S; Zhang B; Li S; Huang L; Czachor A; Breitzig M; Gao Y; Huang M; Mo X; Zheng Q; Sun H; Wang F
    Theranostics; 2020; 10(13):5719-5735. PubMed ID: 32483414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper metabolism-related risk score identifies hepatocellular carcinoma subtypes and SLC27A5 as a potential regulator of cuproptosis.
    Li X; Wang J; Guo Z; Ma Y; Xu D; Fan D; Dai P; Chen Y; Liu Q; Jiao J; Fan J; Wu N; Li X; Li G
    Aging (Albany NY); 2023 Dec; 15(24):15084-15113. PubMed ID: 38157255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant regulation of alternative pre-mRNA splicing in hepatocellular carcinoma.
    Liu L; Xie S; Zhang C; Zhu F
    Crit Rev Eukaryot Gene Expr; 2014; 24(2):133-49. PubMed ID: 24940767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of pre-mRNA splicing in liver disease: mechanisms and consequences.
    Berasain C; Goñi S; Castillo J; Latasa MU; Prieto J; Avila MA
    World J Gastroenterol; 2010 Jul; 16(25):3091-102. PubMed ID: 20593494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing.
    Chen D; Wang Y; Lu R; Jiang X; Chen X; Meng N; Chen M; Xie S; Yan GR
    Theranostics; 2020; 10(19):8558-8572. PubMed ID: 32754263
    [No Abstract]   [Full Text] [Related]  

  • 9. Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors.
    Chettouh H; Fartoux L; Aoudjehane L; Wendum D; Clapéron A; Chrétien Y; Rey C; Scatton O; Soubrane O; Conti F; Praz F; Housset C; Rosmorduc O; Desbois-Mouthon C
    Cancer Res; 2013 Jul; 73(13):3974-86. PubMed ID: 23633480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma.
    Wang XQ; Luk JM; Leung PP; Wong BW; Stanbridge EJ; Fan ST
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):483-9. PubMed ID: 15701831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of ESRP2 Activates TAK1-MAPK Signaling through the Fetal RNA-Splicing Program to Promote Hepatocellular Carcinoma Progression.
    Yan Q; Fang X; Liu X; Guo S; Chen S; Luo M; Lan P; Guan XY
    Adv Sci (Weinh); 2024 Jan; 11(1):e2305653. PubMed ID: 37985644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC00467 promotes cell proliferation and metastasis by binding with IGF2BP3 to enhance the mRNA stability of TRAF5 in hepatocellular carcinoma.
    Jiang W; Cheng X; Wang T; Song X; Zheng Y; Wang L
    J Gene Med; 2020 Mar; 22(3):e3134. PubMed ID: 31656043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of SLC27A5 Activates Hepatic Stellate Cells and Promotes Liver Fibrosis via Unconjugated Cholic Acid.
    Wu K; Liu Y; Xia J; Liu J; Wang K; Liang H; Xu F; Liu D; Nie D; Tang X; Huang A; Chen C; Tang N
    Adv Sci (Weinh); 2024 Jan; 11(2):e2304408. PubMed ID: 37957540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia.
    Lima K; Coelho-Silva JL; Kinker GS; Pereira-Martins DA; Traina F; Fernandes PACM; Markus RP; Lucena-Araujo AR; Machado-Neto JA
    Cancer Genet; 2019 Apr; 233-234():56-66. PubMed ID: 31109595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphiregulin induces the alternative splicing of p73 into its oncogenic isoform DeltaEx2p73 in human hepatocellular tumors.
    Castillo J; Goñi S; Latasa MU; Perugorría MJ; Calvo A; Muntané J; Bioulac-Sage P; Balabaud C; Prieto J; Avila MA; Berasain C
    Gastroenterology; 2009 Nov; 137(5):1805-15.e1-4. PubMed ID: 19664633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased SLC27A5 Suppresses Lipid Synthesis and Tyrosine Metabolism to Activate the Cell Cycle in Hepatocellular Carcinoma.
    Wang J; Qiao Y; Sun H; Chang H; Zhao H; Zhang S; Shan C
    Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
    Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B
    J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis.
    Hong X; Song R; Song H; Zheng T; Wang J; Liang Y; Qi S; Lu Z; Song X; Jiang H; Liu L; Zhang Z
    Gut; 2014 Oct; 63(10):1635-47. PubMed ID: 24352616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Tumor Cell-Based Messenger RNA Scoring System for Prognostication of Hepatocellular Carcinoma: Translating Tissue-Based Messenger RNA Profiling Into a Noninvasive Setting.
    Lee YT; Sun N; Kim M; Wang JJ; Tran BV; Zhang RY; Qi D; Zhang C; Chen PJ; Sadeghi S; Finn RS; Saab S; Han SB; Busuttil RW; Pei R; Zhu Y; Tseng HR; You S; Yang JD; Agopian VG
    Liver Transpl; 2022 Feb; 28(2):200-214. PubMed ID: 34664394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.